From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “narcolepsy type 1” 71

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Narcolepsy type 1 and Sydenham chorea – Report of 3 cases and review of the literature
2023 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Elena Wenz, Mink Sebastian Schinkelshoek, Ulf Kallweit, Rolf Fronczek, Rana Rezaei, Ramin Khatami, +2 more

6

citations
The First Light: Efficacy and Safety of a Multi-Dose Study of Oveporexton (TAK-861), an Oral Orexin Receptor 2 Agonist for the Treatment of Narcolepsy Type 1
2026 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Emmanuel Mignot, Isabelle Arnulf, Giuseppe Plazzi, Rafael del Río Villegas, R. Khatami, G.J. Lammers, +9 more

2

citations
Characterization of the nature, severity, and subjective experience of Cognitive Symptoms Associated with Narcolepsy Type 1
2026 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

G.J. Lammers, P. Maruff, T. Banerjee, Robert H. Pietrzak, H. Romero, Ellie Stukalin, +2 more

1

citations
Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial
2026 The Lancet Neurology article Neuroscience Sleep and Wakefulness Research

Giuseppe Plazzi, Ronald R. Grunstein, Emmanuel Mignot, Gert Jan Lammers, David Thomas Plante, Erik Buntinx, +8 more

0

citations
Improvement in Patient-reported Cognitive Functioning in Patients with Narcolepsy Type 1 Treated with the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680)
2026 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Giuseppe Plazzi, Yves A Dauvilliers, RR Grunstein, Emmanuel Mignot, G.J. Lammers, DT Plante, +7 more

0

citations
Vibrance-1: A Randomized Phase 2 Study Evaluating Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680) in Patients with Narcolepsy Type 1
2026 Sleep Medicine article Neuroscience Sleep and Wakefulness Research

Giuseppe Plazzi, Yves A Dauvilliers, RR Grunstein, Emmanuel Mignot, G.J. Lammers, DT Plante, +6 more

0

citations
2010 and 2013 incidence peaks in narcolepsy and idiopathic hypersomnia linked to type A H1N1 and type B Victoria influenza strains
2024 medRxiv preprint Neuroscience Sleep and Wakefulness Research Open access

Zhongxing Zhang, Jari K. Gool, Pavel Sirotkin, Yves A Dauvilliers, Lucie Barateau, Giuseppe Plazzi, +11 more

0

citations
Improvement in Patient-reported Disease Severity, Cognitive Functioning, and Fatigue in Patients With Narcolepsy Type One Treated With Alixorexton, an Orexin Two Receptor Agonist, in the Vibrance-1 Phase Two Study (P6-14.002)
2026 Neurology article Neuroscience Sleep and Wakefulness Research

Yves A Dauvilliers, Ronald Grunstein, Emmanuel Mignot, Gerrit Lammers, David Plante, Erik Buntinx, +7 more

0

citations
The First Light: Efficacy and Safety of a Multi-dose Study of Oveporexton (TAK-861), an Oral Orexin Receptor Two Agonist for the Treatment of Narcolepsy Type One (S3.010)
2026 Neurology article Neuroscience Sleep and Wakefulness Research

Giuseppe Plazzi, Emmanuel Mignot, Isabelle Arnulf, Rafael del Río Villegas, Ramin Khatami, Gert Jan Lammers, +9 more

0

citations
Études de phase III 3001 et 3002 : efficacité et sécurité de l’oveporexton pour le traitement de la narcolepsie de type 1
2026 Médecine du Sommeil article Neuroscience Sleep and Wakefulness Research

Yves A Dauvilliers, Rafael del Río Villegas, Isabelle Arnulf, Emmanuel Mignot, Ramin Khatami, G.J. Lammers, +8 more

0

citations
Postmortem Evidence of CRH Neuron Reduction in Narcolepsy Without Cataplexy With Borderline Hypocretin‐1 Levels
2026 Journal of Sleep Research article Neuroscience Sleep and Wakefulness Research Open access

Ling Shan, Suzan Linssen, Rolf Fronczek, Lucie Barateau, Christelle Peyron, Yves A Dauvilliers

0

citations
What triggered narcolepsy: H1N1 vaccination, virus, or both? Important lessons learned from China
2023 SLEEP article Neuroscience Sleep and Wakefulness Research Open access

Jari K. Gool, Mink Sebastian Schinkelshoek, Rolf Fronczek

6

citations
SPHYNCS: The Use of the Swiss Narcolepsy Scale in a New Cohort of Patients with Narcolepsy and Its Borderland and Review of the Literature
2023 Clinical and Translational Neuroscience article Neuroscience Sleep and Wakefulness Research Open access

Kseniia Zub, Jan D. Warncke, Julia van der Meer, Elena Wenz, Livia G. Fregolente, Panagiotis Bargiotas, +12 more

2

citations
Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
2023 Nature Communications article Neuroscience Sleep and Wakefulness Research Open access

Hanna Maria Ollila, Eilon Sharon, Ling Lin, Nasa Sinnott-Armstrong, Aditya Ambati, Selina Maria Yogeshwar, +93 more

66

citations
Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations
2024 Sleep Medicine article Neuroscience Sleep and Wakefulness Research Open access

Jari K. Gool, Zhongxing Zhang, Rolf Fronczek, Pauline Amesz, Ramin Khatami, Gert Jan Lammers

14

citations
Measuring energy expenditure in narcolepsy using doubly labeled water and respiration chamber calorimetry
2024 SLEEP article Neuroscience Sleep and Wakefulness Research Open access

Claire E. H. M. Donjacour, Jari K. Gool, Paul F.M. Schoffelen, Loek Wouters, Sebastiaan Overeem, Gert Jan Lammers, +2 more

1

citations
Corticotropin‐Releasing Hormone ( CRH ) in Murine Narcolepsy: What Do Genetic and Immune Models Tell Us?
2025 Journal of Sleep Research article Neuroscience Sleep and Wakefulness Research Open access

Jingru Zhou, Silvia Melzi, Anne‐Laure Morel, Béatrice Georges, Thomas E. Scammell, Gert Jan Lammers, +2 more

1

citations
New 2013 incidence peak in childhood narcolepsy: more than vaccination?
2020 SLEEP article Neuroscience Sleep and Wakefulness Research Open access

Zhongxing Zhang, Jari K. Gool, Rolf Fronczek, Yves A Dauvilliers, Claudio L. Bassetti, Geert Mayer, +22 more

23

citations
iSPHYNCS: Unsupervised clustering in questionnaires and metadata reveals distinct subtypes in the narcolepsy borderland
2025 medRxiv preprint Neuroscience Sleep and Wakefulness Research Open access

Rafael Morand, Livia G. Fregolente, Julia van der Meer, Elena Wenz, Annina Helmy, Lorenzo Brigato, +12 more

0

citations
iSPHYNCS : Unsupervised Clustering in Questionnaires and Metadata Reveals Distinct Subtypes in the Narcolepsy Borderland
2026 Journal of Sleep Research article Neuroscience Sleep and Wakefulness Research Open access

Rafael Morand, Livia G. Fregolente, Julia van der Meer, Elena Wenz, Annina Helmy, Lorenzo Brigato, +14 more

2

citations
Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis
2022 Nature and Science of Sleep article Neuroscience Sleep and Wakefulness Research Open access

Zhongxing Zhang, Yves A Dauvilliers, Giuseppe Plazzi, Geert Mayer, Gert Jan Lammers, Joan Santamaría, +20 more

65

citations
School Problems and School Support for Children with Narcolepsy: Parent, Teacher, and Child Reports
2023 International Journal of Environmental Research and Public Health article Neuroscience Sleep and Wakefulness Research Open access

Karin A.M. Janssens, Pauline Amesz, Yvonne Nuvelstijn, Claire E. H. M. Donjacour, Daniëlle M. Hendriks, Els A. J. Peeters, +4 more

7

citations
Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy
2023 Proceedings of the National Academy of Sciences article Neuroscience Sleep and Wakefulness Research Open access

Ali Seifinejad, Mergim Ramosaj, Ling Shan, Sha Li, Marie-Laure Possovre, Corinne Pfister, +15 more

65

citations
Narcolepsy with cataplexy is caused by epigenetic silencing of hypocretin neurons
2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Neuroscience Sleep and Wakefulness Research Open access

Ali Seifinejad, Almar Neiteler, Sha Li, Corinne Pfister, Rolf Fronczek, Ling Shan, +13 more

9

citations
Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial
2023 The Lancet Neurology article Neuroscience Sleep and Wakefulness Research Open access

Yves A Dauvilliers, Michel Lecendreux, Gert Jan Lammers, Patricia Franco, Mikhail Gur'evich Poluektov, Christian Caussé, +2 more

112

citations